Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
3.01
- 0.07 (-2.12%)
12:08 PM ET on Jun 29, 2016
Delayed at least 20 minutes.
Day High 3.16
Day Low 2.80
52-Week High 11.65
Volume 534,128
Print Friendly